Resultats de la cerca - Michael Staehler

Refinar resultats
  1. 1
    Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal Carcinoma

    Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal Carcinoma per Ulka N. Vaishampayan, Sumanta K. Pal, Sephora Dafinescu, Neha D. Shah, Dena Battle, Michael Staehler

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study

    Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study per Nikolaos Pyrgidis, Gerald Bastian Schulz, Christian G. Stief, Iulia Blajan, Troya Ivanova, Annabel Graser, Michael Staehler

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Perioperative Outcomes After Radical Nephrectomy with Inferior Vena Cava Thrombectomy

    Perioperative Outcomes After Radical Nephrectomy with Inferior Vena Cava Thrombectomy per Nikolaos Pyrgidis, Gerald Bastian Schulz, Christian G. Stief, Iulia Blajan, Troya Ivanova, Annabel Spek, Michael Staehler

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry

    Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry per Norbert Marschner, Michael Staehler, Lothar Müller, Arnd Nusch, Johanna Harde, M T Koska, Martina Jänicke, Peter J. Goebell

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review

    Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review per I. Ouzaïd, Umberto Capitanio, Michael Staehler, Christopher G. Wood, Bradley C. Leibovich, Börje Ljungberg, Hendrik Van Poppel, Karim Bensalah

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Local treatments for metastases of renal cell carcinoma: a systematic review

    Local treatments for metastases of renal cell carcinoma: a systematic review per Saeed Dabestani, Lorenzo Marconi, Fabian Hofmann, Fiona Stewart, Thomas Lam, Steven Canfield, Michael Staehler, Thomas Powles, Börje Ljungberg, Axel Bex

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?

    Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver? per Severin Rodler, Maria Apfelbeck, Gerald Bastian Schulz, Troya Ivanova, Alexander Büchner, Michael Staehler, Volker Heinemann, Christian G. Stief, Jozefina Casuscelli

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    1241: An International Multicenter Study of the Treatment of Female Recurrent Stress Urinary Incontinence using the Minimally Invasive Adjustable Continence Therapy (ACT)

    1241: An International Multicenter Study of the Treatment of Female Recurrent Stress Urinary Incontinence using the Minimally Invasive Adjustable Continence Therapy (ACT) per Michael Staehler, Thilo Sauter, Ervin Kocjancic, P Costa, Aparecida Maria Pacetta, Marcus Vinícius Sadi, Emmanuel Chartier‐Kastler, Roberto Carone, Johann Wachter, Ulrich Maier, Joel Slutsky

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?

    Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? per Jan‐Niclas Mumm, Andreas Osterman, Michael Ruzicka, Clemens Stihl, Theresa� Vilsmaier, Dieter Munker, Elham Khatamzas, Clemens Gießen-Jung, Christian G. Stief, Michael Staehler, Severin Rodler

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

    Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives per Sean Berquist, Kendrick Yim, Stephen Ryan, Sunil Patel, Ahmed Eldefrawy, Brittney Cotta, Aaron Bradshaw, Margaret Meagher, Ahmet Bindayı, Rana R. McKay, Riccardo Autorino, Michael Staehler, Ithaar Derweesh

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast‐enhanced MRI: A pilot study

    Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast‐enhanced MRI: A pilot study per Mike Notohamiprodjo, Steven Sourbron, Michael Staehler, Henrik J. Michaely, Ulrike Attenberger, Gerwin P. Schmidt, Holger F. Boehm, Annie Horng, Christian Gläser, Christian G. Stief, Maximilian F. Reiser, Karin A. Herrmann

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings per Jochaim Beck, Giuseppe Procopio, Emilio Bajetta, Ulrich Keilholz, Sylvie Négrier, Cezary Szczylik, Carsten Bokemeyer, Sergio Bracarda, D. J. Richel, Michael Staehler, U.P. Strauss, Sabine Mersmann, K. Burock, Bernard Escudier

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register

    Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register per Nikolaos Pyrgidis, Yannic Volz, Benedikt Ebner, Thilo Westhofen, Michael Staehler, Michael Chaloupka, Maria Apfelbeck, Friedrich Jokisch, Robert Bischoff, Julian Marcon, Philipp Weinhold, Armin Becker, Christian G. Stief, Gerald Bastian Schulz

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma

    An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma per Viktor Grünwald, Berit Eberhardt, Axel Bex, Anne Flörcken, Thomas Gauler, Thorsten Derlin, Martin Panzica, Hans Roland Dürr, Knut A. Grötz, Rachel H. Giles, Christian von Falck, Anno Graser, Alexander Muacevic, Michael Staehler

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    EAU Guidelines on Renal Cell Carcinoma: 2014 Update

    EAU Guidelines on Renal Cell Carcinoma: 2014 Update per Börje Ljungberg, Karim Bensalah, Steven Canfield, Saeed Dabestani, Fabian Hofmann, Milan Hora, Markus A. Kuczyk, Thomas Lam, Lorenzo Marconi, Axel S. Merseburger, Peter F.A. Mulders, Thomas Powles, Michael Staehler, Alessandro Volpe, Axel Bex

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)

    Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) per Shankar Siva, Alexander V. Louie, Andrew Warner, Alexander Muacevic, Senthilkumar Gandhidasan, Lee Ponsky, Rodney J. Ellis, Irving Kaplan, Anand Mahadevan, William Chu, Anand Swaminath, Hiroshi Onishi, Bin S. Teh, Rohann Correa, Simon S. Lo, Michael Staehler

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

    Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib per Brian I. Rini, Bernard Escudier, Jean-François Martini, Ahmed Magheli, Christer Svedman, Margarita Lopatin, Dejan Knezevic, Audrey D. Goddard, Phillip G. Febbo, Rachel Li, Xun Lin, Olga Valota, Michael Staehler, Robert J. Motzer, Alain Ravaud

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy

    Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy per Lorenzo Marconi, Saeed Dabestani, Thomas Lam, Fabian Hofmann, Fiona Stewart, John Norrie, Axel Bex, Karim Bensalah, Steven Canfield, Milan Hora, Markus A. Kuczyk, Axel S. Merseburger, Peter F.A. Mulders, Thomas Powles, Michael Staehler, Börje Ljungberg, Alessandro Volpe

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

    Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial per Bernard Escudier, M. Dror Michaelson, Robert J. Motzer, Thomas E. Hutson, Joseph I. Clark, Ho Yeong Lim, Emilio Porfiri, Paweł Zalewski, George Kannourakis, Michael Staehler, Jamal Tarazi, Brad Rosbrook, Laura A. Cisar, Seetharaman Hariharan, S. Kim, Brian I. Rini

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial

    Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial per Michael Staehler, Robert J. Motzer, Daniel J. George, Hardev Pandha, Frede Donskov, Bernard Escudier, A.J. Pantuck, Anup Patel, Liza DeAnnuntis, Helen Bhattacharyya, Krishnan Ramaswamy, Giovanni Zanotti, Xun Lin, Mariajosé Lechuga, Lucile Serfass, Jean Paty, Alain Ravaud

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: